Aluevahti Try for free

Oy Citotest Ab

Limited company, Pietarsaari. Diagnostic imaging services and medical laboratory activities.

Oy Citotest Ab is a limited company based in Pietarsaari, registered in 1978. The company has been in liquidation since 13.5.2026. In the financial year ending 31.12.2025, operating profit -23 t€; equity ratio -7.0 %. Its taxable income in 2024 was 5 662 € and its income taxes 1 132 €. Latest Trade Register entry: liquidation, 27.5.2026.

Gross profit 2025162 t€-2 % on the previous year
Operating profit-23 t€
Net profit-23 t€EBITDA -26 t€
Equity ratio-7,0 %quick ratio 0,78
Taxable income 20245 662 € lower half of its industry
Income taxes 20241 132 €10 t€ in 2020–2024
In business48 yrsregistered 10.3.1978
Trade Register1entries, latest: liquidation
StatusIn liquidationsince 13.5.2026

Financials

241 t€256 t€274 t€200 t€165 t€162 t€162 t€-25 t€4 596 €44 t€13 t€3 361 €-23 t€-25 t€19 t€38 t€12 t€4 472 €-23 t€202020212022202320242025
Gross profitOperating profitNet profit
Key figures31.12.202531.12.202431.12.202331.12.202231.12.202131.12.2020
Revenue change-1,8 %-17,7 %-26,9 %7,1 %6,3 %–
Gross profit162 t€165 t€200 t€274 t€256 t€241 t€
EBITDA-26 t€7 139 €18 t€51 t€13 t€-15 t€
Operating profit-23 t€3 361 €13 t€44 t€4 596 €-25 t€
Net profit-23 t€4 472 €12 t€38 t€19 t€-25 t€
Personnel costs-141 t€120 t€119 t€132 t€157 t€168 t€
Equity ratio-7,0 %76,7 %60,7 %76,5 %72,7 %73,4 %
Quick ratio0,783,802,273,602,752,98
Current ratio0,823,872,333,832,963,12
Return on equity–5,1 %14,6 %30,4 %21,9 %-19,0 %
Balance sheet total66 t€115 t€138 t€165 t€121 t€181 t€
Equity-4 619 €88 t€83 t€126 t€88 t€133 t€
Cash and bank24 t€65 t€91 t€90 t€38 t€41 t€

Balance sheet

181 t€121 t€165 t€138 t€115 t€66 t€66 t€133 t€88 t€126 t€83 t€88 t€-4 619 €41 t€38 t€90 t€91 t€65 t€24 t€202020212022202320242025
Balance sheet totalEquityCash
Income statement and balance sheet

Income statement

31.12.202531.12.202431.12.202331.12.202231.12.202131.12.2020
Gross profit or loss162 t€165 t€200 t€274 t€256 t€241 t€
Personnel expenses141 t€-120 t€-119 t€-132 t€-157 t€-168 t€
Depreciations and reductions in value2 728 €-3 778 €-5 146 €-6 378 €-8 020 €-10 t€
Other operating expenses41 t€-38 t€-64 t€-92 t€-86 t€-87 t€
Operating profit (loss)-23 t€3 361 €13 t€44 t€4 596 €-25 t€
Financial income and expenses + (-)-796 €2 243 €2 694 €100 €15 t€36 €
Profit (loss) before appropriations and taxes-23 t€5 604 €15 t€44 t€19 t€-25 t€
Income taxes0 €-1 132 €-3 066 €-6 053 €0 €–
Profit (loss) for the financial year-23 t€4 472 €12 t€38 t€19 t€-25 t€

Balance sheet

31.12.202531.12.202431.12.202331.12.202231.12.202131.12.2020
Non-current assets8 391 €11 t€11 t€17 t€23 t€31 t€
Stocks2 388 €1 958 €3 384 €9 087 €7 153 €6 744 €
Receivables17 t€22 t€17 t€35 t€38 t€38 t€
Cash in hand and at banks24 t€65 t€91 t€90 t€38 t€41 t€
Current assets58 t€104 t€126 t€148 t€98 t€150 t€
Assets66 t€115 t€138 t€165 t€121 t€181 t€
Share capital or other similar capital17 t€17 t€17 t€17 t€17 t€17 t€
Capital and reserves-4 619 €88 t€83 t€126 t€88 t€133 t€
Short-term liabilities71 t€27 t€54 t€39 t€33 t€48 t€
Liabilities71 t€27 t€54 t€39 t€33 t€48 t€
All financial statement items (46)
31.12.202531.12.202431.12.202331.12.202231.12.202131.12.2020
Gross profit or loss162 t€165 t€200 t€274 t€256 t€241 t€
Personnel expenses141 t€-120 t€-119 t€-132 t€-157 t€-168 t€
Depreciations and reductions in value2 728 €-3 778 €-5 146 €-6 378 €-8 020 €-10 t€
Other operating expenses41 t€-38 t€-64 t€-92 t€-86 t€-87 t€
Operating profit (loss)-23 t€3 361 €13 t€44 t€4 596 €-25 t€
Financial income and expenses + (-)-796 €2 243 €2 694 €100 €15 t€36 €
Profit (loss) before appropriations and taxes-23 t€5 604 €15 t€44 t€19 t€-25 t€
Income taxes0 €-1 132 €-3 066 €-6 053 €0 €–
Profit (loss) for the financial year-23 t€4 472 €12 t€38 t€19 t€-25 t€
Non-current assets8 391 €11 t€11 t€17 t€23 t€31 t€
Stocks2 388 €1 958 €3 384 €9 087 €7 153 €6 744 €
Receivables17 t€22 t€17 t€35 t€38 t€38 t€
Cash in hand and at banks24 t€65 t€91 t€90 t€38 t€41 t€
Current assets58 t€104 t€126 t€148 t€98 t€150 t€
Assets66 t€115 t€138 t€165 t€121 t€181 t€
Share capital or other similar capital17 t€17 t€17 t€17 t€17 t€17 t€
Capital and reserves-4 619 €88 t€83 t€126 t€88 t€133 t€
Short-term liabilities71 t€27 t€54 t€39 t€33 t€48 t€
Liabilities71 t€27 t€54 t€39 t€33 t€48 t€
Other current liabilities2 868 €2 764 €27 t€2 748 €3 299 €3 224 €
Wages and salaries118 t€-101 t€-99 t€-110 t€-132 t€-144 t€
Income from other investments under non-current assets, from other companies30 €30 €30 €30 €15 t€30 €
Pension expenses20 t€-17 t€-17 t€-19 t€-22 t€-21 t€
Tangible assets8 183 €11 t€11 t€15 t€20 t€26 t€
Intangible assets–0 €141 €1 592 €3 043 €4 495 €
Depreciations according to plan2 728 €-3 778 €-5 146 €-6 378 €-8 020 €-10 t€
Liabilities66 t€115 t€138 t€165 t€121 t€181 t€
Other short-term receivables14 €14 €14 €21 €0 €18 €
Investments208 €208 €208 €208 €208 €208 €
Other social security expenses3 098 €-1 873 €-2 581 €-2 577 €-3 234 €-3 464 €
Materials and supplies2 388 €1 958 €3 384 €9 087 €7 153 €6 744 €
Profit (loss) for the period, equity-23 t€4 472 €12 t€38 t€19 t€-25 t€
Other shares and holdings15 t€15 t€15 t€15 t€15 t€64 t€
Short-term liabilities to participating interests40 t€0 €––––
Development expenses–0 €141 €1 592 €3 043 €4 495 €
Retained earnings1 114 €67 t€54 t€71 t€52 t€141 t€
Short-term prepayments and accrued income3 053 €7 754 €1 723 €632 €20 €0 €
Other interest and financial income from non-group companies784 €2 341 €2 687 €75 €8 €6 €
Other shares and similar rights of ownership208 €208 €208 €208 €208 €208 €
Short-term accrued expenses and deferred income22 t€21 t€23 t€27 t€25 t€37 t€
Shares and holdings15 t€15 t€15 t€15 t€15 t€64 t€
Short-term sales receivables14 t€14 t€15 t€34 t€38 t€38 t€
Short-term receivables17 t€22 t€17 t€35 t€38 t€38 t€
Interest expenses and other financial expenses for non-Group companies18 €-128 €-23 €-5 €-15 €0 €
Machinery and equipment8 183 €11 t€11 t€15 t€20 t€26 t€
Short-term accounts payable5 760 €2 614 €3 678 €8 991 €4 423 €7 344 €

From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).

Taxes

0 €0 €30 t€15 t€5 662 €5 662 €20202021202220232024

Measured by taxable income, Oy Citotest Ab is in the lower half of the industry class diagnostic imaging services and medical laboratory activities (31 companies with taxable income; median 50 t€).

Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.

Trade Register events

  • Liquidation

Follow companies in your area

New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.

Try for free